Virta Health announced today that it raised $133 million in a Series E equity financing round led by Tiger Global.
San Francisco-based Virta said in a news release that the funds will accelerate its efforts to drive the adoption of its telehealth-based diabetes reversal treatment that aims to reverse the chronic disease while removing the need for costly medications including insulin.
Get the full story at our sister site, Drug Delivery Business News.